Buprenorphine: Keeping Up with the Changing Landscape of Office Based Opioid Treatment

Dates

Oct 10
Buprenorphine

May 1
Buprenorphine

Who Should Attend?

This special update course is for Buprenorphine certified physicians or Clinic-Office Managers who seek to enhance their ability to effectively, efficiently and safely prescribe buprenorphine while minimizing abuse and limiting liability.

Statement of Need

Primary care physicians, mental health and addiction treatment providers who prescribe buprenorphine, are faced with the unique clinical challenge of providingdaily doses of an opioid to patients with addictive disease.

  1. There are challenging clinical issues involved: stabilization v. maintenance doses; treating opiate addicted patients who have concomitant chronic intractable pain; treating opiate addicted patients with co-morbid depressive or anxiety disorders or sleep disturbances; and management of opiate medication side-effects are just a few examples.
  2. There are unique ethical issues involved: patient safety v. minimization of disruption to patient daily life and the obligation to the individual patient v. the obligation to the community well-being.
  3. There are unique Patient-Doctor and Patient-Treatment Program issues:  staff splitting by patients; appropriately supervising toxicology testing while maintaining dignity; patient confidentiality concerns v. the need to have data from other providers regarding patient stability; and issues about dose adjustment, level of supervision and documentation.
  4. There are rapidly changing expectations and concerns from regulatory agencies that must be understood and integrated into an evolving standard of care, and documented during increasingly frequent site visits and chart audits.  It is for these reasons that faculty from the CWRU School of Medicine Addiction Psychiatry and Addiction Medicine Fellowship Programs has developed this special buprenorphine update.

Learning Objectives

After attending this course, participants will be able to:

  • Describe the pharmacologic profiles of buprenorphine, other opioids, benzodiazepines, THC and psychostimulants with regards to their interaction with the addiction prone brain.
  • Identify screening and assessment strategies for anxiety / depression / chronic pain / insomnia and approaches to effectively address these in the context of buprenorphine prescribing.
  • Employ techniques relating to minimizing the diversion of buprenorphine.
  • Discuss risk management, office documentation and best practice guidelines for buprenorphine prescribing as well as evolving and emerging State and Federal requirements.

Accreditation

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Register

Four Ways:

  1. Register online by selecting from our calendar of scheduled conferences.
  2. Mail the 2018 Buprenorphine form or 2019 Buprenorphine form with a check payable to Case Western Reserve University or complete the credit card information and send to:
    Continuing Medical Education Program 
    10524 Euclid Avenue
    Cleveland, Ohio 44106-6026
  3. Fax the 2018 Buprenorphine form or 2019 Buprenorphine form and your credit card number to 216.844.8133 or 216.201.6749.
  4. Phone 216.983.1239 or 800.274.8263 with the information requested on the form and your credit card number.

Location + Accommodations

The course will be held at the George S. Dively Conference Center, 11240 Bellflower Rd, Cleveland, Ohio

Recommended Hotel Accommodations - Dively

See map